London stocks were still a touch higher by midday on Wednesday as investors continued to mull the impact of Trump’s trade war ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

Stock prices in London were mixed on Wednesday afternoon, with a share price rise for GSK supporting the FTSE 100, though tariff worries continue to hang over equities. The FTSE 100 index rose 12.01 ...

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side effects.

London stocks nudged higher in early trade on Wednesday as investors mulled disappointing US tech results and continued to ...

(Reuters) - European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo ...

European stocks remained flat in early trading Wednesday, as gains in healthcare were counterbalanced by a decline in ...

China announced on Tuesday that it was launching an anti-trust probe into Google on Tuesday, just moments after trade tariffs ...

Learn how GSK is harnessing the power of technology to improve outcomes for people with cancer.

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

Science and Technology Secretary Peter Kyle said ... “But through our world-leading universities and businesses working in ...